Results 191 to 200 of about 20,878 (216)

Ibrutinib

Reactions Weekly, 2021
  +5 more sources

Ibrutinib

Reactions Weekly, 2023
  +6 more sources

Ibrutinib

Reactions Weekly, 2020
  +6 more sources

Ibrutinib

Reactions Weekly, 2017
  +5 more sources

Ibrutinib

Reactions Weekly, 2016
  +4 more sources

Ibrutinib

Reactions Weekly
  +6 more sources

Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma

Nature Medicine, 2018
Rishu Agarwal, Yih-Chih Chan, Constantine S Tam   +2 more
exaly  

Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma

Cancer Discovery, 2017
Christian Grommes, Alessandro Pastore, Nicolaos J Palaskas   +2 more
exaly  

The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation

Cancer Discovery, 2018
Bonnie K Harrington, Kerry A Rogers, Farrukh T Awan   +2 more
exaly  

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial

Lancet Oncology, The, 2019
Carol Moreno, Richard F Greil, Fatih Demirkan   +2 more
exaly